Mark McDonough

Mark McDonough is President and Chief Executive Officer of CombiMatrix Corporation. Mr. McDonough brings over 17 years of experience in diagnostic health care and life sciences to CombiMatrix. Led by his passion for patient care, he has spent his career growing early-stage and emerging cancer diagnostics, molecular diagnostics and commercial laboratory organizations. In August 2012, Mr. McDonough joined CombiMatrix as Chief Commercial Officer. His efforts to optimize the commercial aspects of CombiMatrix and his focus on prenatal testing had an immediate impact on the company’s long-term strategy and financial success. Mr. McDonough came to CombiMatrix from Pathwork Diagnostics where he was Vice President of Sales and Service. His business acumen was instrumental in driving all phases of the commercial efforts at Pathwork Diagnostics, including sales, reimbursement strategies and market creation of novel diagnostics that fulfilled a critical, yet unmet, need for patients with metastatic disease. Preceding his time at Pathwork Diagnostics, Mr. McDonough held positions of increasing responsibility at US LABS, ultimately assuming the role of Vice President of Sales. He also served in an executive capacity at Dianon and Laboratory Corporation of America — post-acquisition. His contributions as a field sales resource and sales leader from 2002 to 2004 were instrumental in the growth of US LABS from $17 million to $75 million, resulting in its successful acquisition by Laboratory Corporation of America in early 2005. Prior to US LABS, Mr. McDonough was with EMC Corporation and Ventana Medical Systems. Before joining the health care industry, Mr. McDonough was a ranking officer in the United States Navy for six years, where he served as Navigator of the USS Fletcher — DD 992. Mr. McDonough received his bachelor’s degree in finance from Miami University-Ohio.